Gannage M H, Haddad F, Jambart S, Atallah C, Halaby G
Service d'Endocrinologie de l'HDF de France HDF.
J Med Liban. 1996;44(3):134-7.
TSH receptor antibodies (TRAb) was performed by binding assay in seventy-seven patients (47 with Graves disease, 32 with other thyroid abnormalities). The sensitivity and specificity of our assay were respectively 81% and 96.5%. These results were similar to the results found in medical literature. The association of ophthalmopathy with Graves disease does not increase the sensitivity of the test. In this study we conclude that TRAb assay is of great interest in confirming the diagnosis and in the following of Graves disease.
通过结合试验对77例患者（47例格雷夫斯病患者，32例其他甲状腺异常患者）进行促甲状腺激素受体抗体（TRAb）检测。我们检测方法的敏感性和特异性分别为81%和96.5%。这些结果与医学文献中的结果相似。眼病与格雷夫斯病的关联并未提高检测的敏感性。在本研究中，我们得出结论，TRAb检测对于确诊格雷夫斯病及对其进行随访具有重要意义。
